OFFICIAL PUBLICATION OF

by its subsidiary APPco

Enhanced warnings

Megan Haggan 01/02/2021

Boxed warnings are set to be added to the PI and CMI for medicines containing pregabalin and gabapentin These enhanced warnings advise that pregabalin poses a risk of misuse, while both pregabalin and gabapentin pose risks of abuse and dependence. “These risks can lead to serious side effects, some of which can be life-threatening,” the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Enhanced warnings

Previous Praise for PBS expanded listing

Next Covid jab ‘going to go crazy’ in pharmacy

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Praise for PBS expanded listing

Next Covid jab ‘going to go crazy’ in pharmacy

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.